Arrowhead Pharmaceuticals, Inc..
ARWR.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing medicines that treat intractable diseases by silencing the genes that cause them. The company utilizes its proprietary Targeted RNAi Molecule (TRiM™) platform to design and develop novel therapeutics. Their pipeline...Show More
Better Health for All
60
Arrowhead Pharmaceuticals' core business is developing RNAi therapeutics for intractable diseases, with 100% of its pipeline focused on health-positive products. Plozasiran, an RNAi therapeutic, demonstrated a median 80% triglyceride reduction and an 83% reduction in acute pancreatitis risk in Phase 3 studies for familial chylomicronemia syndrome.
1
It has received Breakthrough Therapy, Orphan Drug, and Fast Track Designations from the FDA.
2
Olpasiran is also in Phase 3 trials to lower lipoprotein(a) and reduce coronary heart disease risk.
3
The company's entire R&D budget is dedicated to developing these health-improving therapeutics, indicating greater than 25% investment in health innovation. There is no evidence of revenue from products with negative health outcomes.
4
The company does not provide information on its approach to patents in relation to global health needs.
5
Fair Money & Economic Opportunity
0
Arrowhead Pharmaceuticals is a biopharmaceutical company focused on developing medicines. The provided articles detail its financial performance, drug development progress, and corporate activities, none of which relate to financial services. As the company does not offer lending, deposit services, or any other financial products to consumers, all KPIs under the 'Fair Money & Economic Opportunity' value are not applicable to its business model, aligning with the '0' tier definitions in the rubric for non-financial entities.
1
Fair Pay & Worker Respect
0
No evidence available to assess Arrowhead Pharmaceuticals, Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No specific, concrete data points related to fair trade and ethical sourcing practices, such as fair-trade certification share, audit frequency, forced or child labor incidents, supply chain traceability, remediation speed, ethical clause coverage in supplier contracts, materials risk index, or supplier diversity spend, were found in the provided articles for Arrowhead Pharmaceuticals, Inc.
1
Honest & Fair Business
-50
Arrowhead Pharmaceuticals has a formal whistleblower policy with anonymous reporting options via a website and hotline, and established procedures for handling complaints related to accounting, internal controls, or auditing matters.
1
However, there is no evidence of independent investigation processes. As of October 26, 2011, the company's board had 3 independent and 3 non-independent members, resulting in 50% independent directors, which led to a NASDAQ notice of non-compliance.
2
The company's code of conduct prohibits conflicts of interest, improper benefits, and unfair business practices, and requires disclosure and approval for certain activities, but there is no specific evidence of the policy's enforcement or training frequency.
3
Kind to Animals
-40
Arrowhead Research (ARWR.US) commissioned a chimpanzee experiment in 2013 that was deemed "cruel" and "unnecessary" by scientific authorities.
1
The company performs animal testing for some pharmaceutical products and medical research.
2
This indicates a policy that permits non-essential animal testing.
No War, No Weapons
0
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing medicines. The provided articles, including annual reports, financial statements, and ESG risk assessments, explicitly state that no data relevant to arms contracts, dual-use technology, sales to embargoed regimes, peacebuilding investment, or any other metrics related to the 'No War, No Weapons' value was found.
1
Therefore, there is no evidence to assess the company against any of the specified KPIs.
Planet-Friendly Business
0
No specific, quantitative evidence was found across the provided articles for any of the Planet-Friendly Business KPIs. Information regarding environmental performance, targets, or initiatives was either not present, too general, or described future plans rather than current, measurable outcomes. For instance, while the company has contracted for a solar power generation plant at its San Diego facility and is exploring solar for its Verona site, and two R&D facilities are being built to meet LEED certification standards, these are future-oriented or do not provide current percentage figures for operational energy from renewables or certified buildings.
1
Similarly, a 'robust recycling program' is mentioned, but no waste diversion rate is provided.
2
No data on emissions, water use, supply chain climate transparency, or climate justice initiatives directly addressing climate impacts on vulnerable communities was found.
3
Respect for Cultures & Communities
0
No evidence available to assess Arrowhead Pharmaceuticals, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
Arrowhead Pharmaceuticals reported no material cybersecurity incidents or breaches in the last fiscal year.
1
The company conducts annual cybersecurity training and role-based phishing tests for employees and third-party access holders.
2
No specific incidents of unauthorized data use were reported.
3
Users can request data removal and opt-out of targeted advertising.
4
The company conducts internal and third-party cybersecurity risk assessments and penetration tests.
5
Data retention is based on business needs and legal obligations.
6
The company's cybersecurity program is informed by the NIST CSF, and its privacy notices address GDPR, CCPA, and other relevant regulations.
7
Zero Waste & Sustainable Products
0
No relevant evidence was found in the provided articles to assess Arrowhead Pharmaceuticals, Inc. against the 'Zero Waste & Sustainable Products' ethical value.
1
The articles did not contain any specific, concrete data points for any of the KPIs, such as waste diversion rates, product recyclability, packaging sustainability, or waste reduction initiatives.
2